Searchable abstracts of presentations at key conferences in endocrinology

ea0044p239 | Thyroid | SFEBES2016

Optimising the medical treatment of Graves’ Disease through developing a novel carbimazole dosing-algorithm

Brewster Rosalind , Abbara Ali , Clarke Sophie , Comninos Alexander , Peters Deborah , Sam Amir , Meeran Karim , Dhillo Waljit

Introduction: Graves’ disease is the commonest cause of hyperthyroidism accounting for 80% of all cases. The first line treatment for Graves’ disease in the UK is medical therapy, most frequently using a ‘dose-titration’ regimen. Currently, there is a lack of guidance to aid clinicians in carrying out optimal dose-titration of carbimazole, resulting in a risk of under- or over-treatment. Thus, we aimed to develop a carbimazole dosing-algorithm for the medic...

ea0038oc6.2 | Advances in reproduction and signalling | SFEBES2015

Kisspeptin-54 safely and effectively triggers oocyte maturation during IVF treatment in women at high risk of developing ovarian hyperstimulation syndrome (OHSS)

Abbara Ali , Jayasena Channa , Christopoulos Georgios , Narayanaswamy Shakunthala , Izzi-Engbeaya Chioma , Nijher Gurjinder , Comninos Alexander , Peters Deborah , Buckley Adam , Ratnasabapathy Risheka , Prague Julia , Bloom Stephen , Trew Geoffrey , Dhillo Waljit

Context: IVF treatment is an effective therapy for infertility, but can result in the potentially life-threatening complication ‘ovarian hyperstimulation syndrome’ (OHSS).Objective: To investigate whether kisspeptin-54 can be used to effectively and safely trigger oocyte maturation in women undergoing IVF treatment at high risk of developing OHSS.Design: Phase 2 multi-dose open label randomised clinical trial.<p class...